<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Brexit: finite uncertainty

One might think that planning for uncertainty is something that biotech fir...

Read More

C-Suite challenges and how intellectual property c...

The 2018 C-Suite Challenges in Life Sciences Survey from Biotech & Money/LS...

Read More

C-suite survey uncovers life sciences challenges

For more than three-quarters (78%) of C-level respondents in the life scien...

Read More

In a new age of personalised cancer therapy, is pa...

On 5 September 2018 it was announced that the NHS has struck a deal with No...

Read More

Make Brexit a non-issue for pharma

What is the recipe for keeping business momentum in clinical trials despite...

Read More

Technical notices for a ‘no-deal’ Brexit

The UK government issued a series of ‘technical notices’ on 23 August outli...

Read More

Experimental data in a European patent application...

It is not unusual for an inventor or applicant to ask: “How much experiment...

Read More

Exploring IP best practice in UK life sciences

In 2017, the East of England filed 623 patents via the European Patent Offi...

Read More

Does Brexit affect your European patent strategy?

The process of obtaining patent protection in Europe is unaffected by Brexi...

Read More

Appleyard Lees: Applying in-house expertise to dev...

Key learnings: UK-based Appleyard Lees provides clients worldwide with a fu...

Read More

Five misconceptions about whistleblowing systems p...

Would you like to be able to identify risk - whether it be reputational, fi...

Read More

Data privacy regulation and the advance of new tec...

If you were not previously aware of the General Data Protection Regulation ...

Read More

Add Your Response